Seeing Is Believing
Currently out of the existing stock ratings of Daniil Gataulin, 72 are a BUY (85.71%), 12 are a HOLD (14.29%).
Analyst Daniil Gataulin, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 22.54% that have a potential upside of 33.92% achieved within 107 days.
Daniil Gataulin’s has documented 144 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OCS, Oculis Holding AG Ordinary shares at 07-Oct-2025.
Analyst best performing recommendations are on QURE (UNIQURE NV).
The best stock recommendation documented was for QURE (UNIQURE NV) at 9/8/2025. The price target of $35 was fulfilled within 16 days with a profit of $17.57 (100.8%) receiving and performance score of 63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
19 days ago
(23-Sep-2025)
0/4 (0%)
$23.75 (380.00%)
Buy
1 months 29 days ago
(13-Aug-2025)
3/4 (75%)
$30.52 (321.94%)
884
Buy
$12
$7.19 (149.48%)
$16
3 months 17 days ago
(25-Jun-2025)
1/4 (25%)
$9.42 (365.12%)
292
Hold
$4
$-0.81 (-16.84%)
$5
4 months 27 days ago
(15-May-2025)
3/5 (60%)
$1.95 (95.12%)
127
Buy
$6
$4.05 (207.69%)
$4
2 years 1 months 7 days ago
(05-Sep-2023)
4/7 (57.14%)
$4.22 (237.08%)
196
Which stock is Daniil Gataulin is most bullish on?
Which stock is Daniil Gataulin is most reserved on?
What Year was the first public recommendation made by Daniil Gataulin?